Science Explorer Back to mapMap

Most cited papers in Pharmaceutical Quality and Counterfeiting

Pharmaceutical Quality and Counterfeiting

What are the most cited papers in Pharmaceutical Quality and Counterfeiting?

The most cited paper in Pharmaceutical Quality and Counterfeiting is "Spread of Artemisinin Resistance in Plasmodium falciparum Malaria" (Elizabeth A. Ashley et al., 2014), with 2,295 citations. Next come "Oral Sildenafil in the Treatment of Erectile Dysfunction" (2,158) and "Internet of Things: Applications and Challenges in Technology and Standardization" (1,499).

Showing 50 of 99 papers. Every paper with more than 268 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Spread of Artemisinin Resistance in Plasmodium falciparum Malaria Elizabeth A. Ashley et al. · New England Journal of Medicine Open access 30 Jul 2014 2,295
2 Oral Sildenafil in the Treatment of Erectile Dysfunction Irwin Goldstein, Tom F. Lue, Harin Padma-Nathan et al. · New England Journal of Medicine 14 May 1998 2,158
3 Internet of Things: Applications and Challenges in Technology and Standardization Debasis Bandyopadhyay, Jaydip Sen · Wireless Personal Communications 8 Apr 2011 1,499
4 An analysis of the attrition of drug candidates from four major pharmaceutical companies Michael J. Waring, John E. Arrowsmith, Andrew R. Leach et al. · Nature Reviews Drug Discovery Review 19 Jun 2015 1,467
5 The threat of antimicrobial resistance in developing countries: causes and control strategies James Ayukepi Ayukekbong, Michel L. Ntemgwa, Andrew N. Atabe · Antimicrobial Resistance and Infection Control Open access 15 May 2017 1,356
6 Origin of Antibiotics and Antibiotic Resistance, and Their Impacts on Drug Development: A Narrative Review Ghazala Muteeb, Md Tabish Rehman, Moyad Jamal Shahwan et al. · Pharmaceuticals ReviewOpen access 15 Nov 2023 1,055
7 A Molecular Marker for Chloroquine-Resistant Falciparum Malaria ABDOULAYE A. DJIMDÉ, O K Doumbo, Joseph F. Cortese et al. · New England Journal of Medicine Open access 25 Jan 2001 1,035
8 Evidence of Artemisinin-Resistant Malaria in Africa Betty Balikagala, Naoyuki Fukuda, Mie Ikeda et al. · New England Journal of Medicine Open access 22 Sep 2021 972
9 Defining the Public Health Threat of Food Fraud John Spink, Douglas C. Moyer · Journal of Food Science Nov 2011 850
10 Increased Risk of Non-Fatal Myocardial Infarction Following Testosterone Therapy Prescription in Men William D. Finkle, Sander Greenland, Greg K. Ridgeway et al. · PLoS ONE Open access 29 Jan 2014 733
11 Effects of the presence of sulfonamides in the environment and their influence on human health Wojciech Baran, Ewa Adamek, Justyna Ziemiańska et al. · Journal of Hazardous Materials 7 Sep 2011 727
12 Prevalence and hazardous impact of pharmaceutical and personal care products and antibiotics in environment: A review on emerging contaminants Preeti Chaturvedi, Parul Shukla, Balendu Shekher Giri et al. · Environmental Research 2 Jan 2021 715
13 Self-medication: A current challenge Darshana Bennadi · Journal of Basic and Clinical Pharmacy Open access 2014 680
14 Novel phenotypic assays for the detection of artemisinin-resistant Plasmodium falciparum malaria in Cambodia: in-vitro and ex-vivo drug-response studies Benoît Witkowski, Chanaki Amaratunga, Nimol Khim et al. · The Lancet Infectious Diseases Open access 10 Sep 2013 665
15 Short, Highly Effective, and Inexpensive Standardized Treatment of Multidrug-resistant Tuberculosis Armand Van Deun, Aung Kya Jai Maug, Md Abdul Hamid Salim et al. · American Journal of Respiratory and Critical Care Medicine 4 May 2010 660
16 National Survey of Drug-Resistant Tuberculosis in China Yanlin Zhao, Shaofa Xu, Lixia Wang et al. · New England Journal of Medicine Open access 7 Jun 2012 653
17 Testosterone Measured by 10 Immunoassays and by Isotope-Dilution Gas Chromatography–Mass Spectrometry in Sera from 116 Men, Women, and Children Joëlle Taieb, B Mathian, F Millot et al. · Clinical Chemistry Aug 2003 639
18 Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature Igho Onakpoya, Carl J Heneghan, Jeffrey K Aronson · BMC Medicine ReviewOpen access 25 Jan 2016 632
19 Sildenafil for Treatment of Erectile Dysfunction in Men With Diabetes Marc Rendell, Jacob Rajfer, Pierre A. Wicker et al. · JAMA 3 Feb 1999 616
20 EFFECTS OF SILDENAFIL ON THE RELAXATION OF HUMAN CORPUS CAVERNOSUM TISSUE IN VITRO AND ON THE ACTIVITIES OF CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ISOZYMES Stephen A. Ballard, CLIVE J. GINGELL, Kim Tang et al. · The Journal of Urology Jun 1998 592
21 Influence of Patients’ Requests for Direct-to-Consumer Advertised Antidepressants Richard L. Kravitz, Ronald M. Epstein, Mitchell D. Feldman et al. · JAMA Open access 26 Apr 2005 591
22 Sildenafil, a novel effective oral therapy for male erectile dysfunction Mitra Boolell, S Gepi-Attee, J. Clive Gingell et al. · British Journal of Urology Aug 1996 576
23 Antibiotics bioremediation: Perspectives on its ecotoxicity and resistance Mohit Kumar, Shweta Jaiswal, Kushneet Kaur Sodhi et al. · Environment International Open access 24 Jan 2019 559
24 Effects of Supraphysiologic Doses of Testosterone on Mood and Aggression in Normal Men Harrison Graham Pope, Elena M. Kouri, James I. Hudson · Archives of General Psychiatry Feb 2000 552
25 Efficacy and Safety of Tadalafil for the Treatment of Erectile Dysfunction: Results of Integrated Analyses Gerald B Brock, Chris G. McMahon, K.K. Chen et al. · The Journal of Urology Oct 2002 542
26 Dihydroartemisinin–piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study Chanaki Amaratunga, Pharath Lim, Seila Suon et al. · The Lancet Infectious Diseases Open access 7 Jan 2016 530
27 Household antimicrobial self-medication: a systematic review and meta-analysis of the burden, risk factors and outcomes in developing countries Moses Ocan, Ekwaro Anthony Obuku, Freddie Bwanga et al. · BMC Public Health ReviewOpen access 31 Jul 2015 530
28 Assessment of WHO antibiotic consumption and access targets in 76 countries, 2000–15: an analysis of pharmaceutical sales data Eili Y. Klein, Maja Milkowska-Shibata, Katie K Tseng et al. · The Lancet Infectious Diseases 24 Jul 2020 524
29 Clinical and Biochemical Assessment of Hypogonadism in Men With Type 2 Diabetes Dheeraj Kapoor, Hazel Aldred, S. Michael Clark et al. · Diabetes Care Open access 29 Mar 2007 493
30 Association of Plasmodium falciparum kelch13 R561H genotypes with delayed parasite clearance in Rwanda: an open-label, single-arm, multicentre, therapeutic efficacy study Aline Uwimana et al. · The Lancet Infectious Diseases Open access 15 Apr 2021 492
31 Antibiotic development — economic, regulatory and societal challenges Christine Årdal, Manica Balasegaram, Ramanan Laxminarayan et al. · Nature Reviews Microbiology ReviewOpen access 19 Nov 2019 466
32 Self-medication and non-doctor prescription practices in Pokhara valley, Western Nepal: a questionnaire-based study P Ravi Shankar, P Partha, Nagesh Shenoy · BMC Family Practice Open access 17 Sep 2002 465
33 Minimal Clinically Important Differences in the Erectile Function Domain of the International Index of Erectile Function Scale Raymond C. Rosen, Kerstin R. Allen, Xiao Ni et al. · European Urology 3 Aug 2011 457
34 Guest authorship and ghostwriting in publications related to rofecoxib: a case study of industry documents from rofecoxib litigation. Joseph S. Ross, Kevin P. Hill, David Steven Egilman et al. · PubMed 16 Apr 2008 456
35 Global access to antibiotics without prescription in community pharmacies: A systematic review and meta-analysis Asa Auta, Muhammad Abdul Hadi, Enoche Florence Oga et al. · Journal of Infection ReviewOpen access 5 Jul 2018 443
36 Return of Chloroquine Antimalarial Efficacy in Malawi Miriam K. Laufer, Phillip C. Thesing, Nicole D. Eddington et al. · New England Journal of Medicine Open access 8 Nov 2006 442
37 Pharmacy practice and its challenges in Yemen Yaser Mohammed Al‐Worafi · Australasian Medical Journal Open access 30 Jan 2014 441
38 Combating Sale of Counterfeit and Falsified Medicines Online: A Losing Battle Kah Seng Lee, Siew Mei Yee, Syed Tabish Razi Zaidi et al. · Frontiers in Pharmacology Open access 16 May 2017 440
39 Spread of artemisinin-resistant Plasmodium falciparum in Myanmar: a cross-sectional survey of the K13 molecular marker Kyaw Myo Tun et al. · The Lancet Infectious Diseases Open access 19 Feb 2015 437
40 Genetic markers associated with dihydroartemisinin–piperaquine failure in Plasmodium falciparum malaria in Cambodia: a genotype–phenotype association study Roberto Amato, Pharath Lim, Olivo Miotto et al. · The Lancet Infectious Diseases Open access 3 Nov 2016 434
41 Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study Rob W. van der Pluijm et al. · The Lancet Infectious Diseases Open access 22 Jul 2019 421
42 Poor-quality antimalarial drugs in southeast Asia and sub-Saharan Africa Gaurvika M. L. Nayyar, Joel G. Breman, Paul N. Newton et al. · The Lancet Infectious Diseases 22 May 2012 415
43 A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: a phenotype–genotype association study Benoît Witkowski et al. · The Lancet Infectious Diseases Open access 3 Nov 2016 409
44 A Trial of a Shorter Regimen for Rifampin-Resistant Tuberculosis Andrew Nunn, Patrick P. J. Phillips, Sarah K Meredith et al. · New England Journal of Medicine Open access 13 Mar 2019 407
45 RANDOMIZED STUDY OF TESTOSTERONE GEL AS ADJUNCTIVE THERAPY TO SILDENAFIL IN HYPOGONADAL MEN WITH ERECTILE DYSFUNCTION WHO DO NOT RESPOND TO SILDENAFIL ALONE Ridwan Shabsigh, Joel M. Kaufman, Christopher P. Steidle et al. · The Journal of Urology 2 Jul 2004 402
46 A Blockchain-Based Approach for Drug Traceability in Healthcare Supply Chain Ahmad Musamih, Khaled Salah, Raja Jayaraman et al. · IEEE Access Open access 2021 399
47 High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial Martin Johan Boeree et al. · The Lancet Infectious Diseases Open access 26 Oct 2016 393
48 Herbal medicines safety issues Yaser Mohammed Al‐Worafi · Elsevier eBooks Book chapter 2020 388
49 Access to Essential Drugs in Poor Countries Bernard Pécoul, Pierre Chirac, Patrice Trouiller et al. · JAMA 27 Jan 1999 385
50 Counterfeit and substandard medications Yaser Mohammed Al‐Worafi · Elsevier eBooks Book chapter 2020 380

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for a field when OpenAlex files it under one of the field's topics; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.